Xuejie Jiang

机构：Nanfang Hospital, Southern Medical University · ORCID：0000-0002-0178-691X

发表论文 93 篇 · 总被引 745 次 · h-index 15

代表论文

• Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study (2024 · Clinical Cancer Research · 被引 12)
• Thermoresponsive dynamic wet-adhesive epidermal interface for motion-robust multiplexed sweat biosensing (2025 · Biosensors and Bioelectronics · 被引 9)
• Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis (2024 · Cell Communication and Signaling · 被引 9)
• Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation (2025 · Frontiers in Medicine · 被引 4)
• Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia (2025 · Therapeutic Advances in Hematology · 被引 3)
• Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia‐related mutations in first remission (2024 · British Journal of Haematology · 被引 3)